UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 54

Sortiert nach

PPARγ is reduced in the airways of non-CF bronchiectasis subjects and is inversely correlated with the presence of Pseudomonas aeruginosa

PloS one, 2018-08, Vol.13 (8), p.e0202296-e0202296

2018

Link zum Volltext

Verfügbarkeit prüfen

Adult non-cystic fibrosis bronchiectasis is characterised by airway luminal Th17 pathway activation

PloS one, 2015-03, Vol.10 (3), p.e0119325-e0119325

2015

Link zum Volltext

Verfügbarkeit prüfen

Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial

JAMA : the journal of the American Medical Association, 2013-03, Vol.309 (12), p.1260

2013

Link zum Volltext

Verfügbarkeit prüfen

Airway Mucus Hyperconcentration in Non-Cystic Fibrosis Bronchiectasis

American journal of respiratory and critical care medicine, 2020-03, Vol.201 (6), p.661-670

2020

Link zum Volltext

Verfügbarkeit prüfen

Central Sleep Apnea in Cancer Patients on Opioids

Journal of pain and symptom management, 2010-09, Vol.40 (3), p.e3-e5

2010

Link zum Volltext

Verfügbarkeit prüfen

Effect of Albuterol on Maximal Exercise Capacity in Cystic Fibrosis

Chest, 2007-04, Vol.131 (4), p.1181-1187

2007

Link zum Volltext

Verfügbarkeit prüfen

Macrolide Treatment Inhibits Pseudomonas aeruginosa Quorum Sensing in Non-Cystic Fibrosis Bronchiectasis. An Analysis from the Bronchiectasis and Low-Dose Erythromycin Study Trial

Annals of the American Thoracic Society, 2016-10, Vol.13 (10), p.1697-1703

2016

Link zum Volltext

Verfügbarkeit prüfen

Australasian respiratory and emergency physicians do not use the pneumonia severity index in community-acquired pneumonia

Respirology (Carlton, Vic.), 2013-02, Vol.18 (2), p.291-296

2013

Link zum Volltext

Verfügbarkeit prüfen

Severe asthma assessment, management and the organisation of care in Australia and New Zealand: expert forum roundtable meetings

Internal medicine journal, 2021-02, Vol.51 (2), p.169-180

2021

Link zum Volltext

Verfügbarkeit prüfen

Everolimus treatment of abdominal lymphangioleiomyoma in five women with sporadic lymphangioleiomyomatosis

Medical journal of Australia, 2013-07, Vol.199 (2), p.121-123

2013

Link zum Volltext

Verfügbarkeit prüfen

Effect of long-term treatment with azithromycin on disease parameters in cystic fibrosis

Japanese journal of antibiotics, 2003-04, Vol.56 Suppl A, p.38-38

Bowler, Simon D

2003

Link zum Volltext

Verfügbarkeit prüfen

Successful Treatment of Severe Cytomegalovirus Infection with Ganciclovir in an Immunocompetent Host

Clinical infectious diseases, 1998-04, Vol.26 (4), p.1007-1008

1998

Link zum Volltext

Verfügbarkeit prüfen

Buteyko breathing techniques in asthma: a blinded randomised controlled trial

Medical journal of Australia, 1998-12, Vol.169 (11-12), p.575-578

1998

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis

The New England journal of medicine, 2020-11, Vol.383 (22), p.2127-2137

2020

Link zum Volltext

Verfügbarkeit prüfen

Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study

American journal of respiratory and critical care medicine, 2018-12, Vol.198 (12), p.1559-1569

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinical and epidemiological profile of patients with severe H1N1/09 pandemic influenza in Australia and New Zealand: an observational cohort study

BMJ open, 2011-01, Vol.1 (1), p.e000100-e000100

2011

Link zum Volltext

Verfügbarkeit prüfen

Effect of a simple educational intervention on the hospital management of community-acquired pneumonia

Respirology (Carlton, Vic.), 2007-05, Vol.12 (3), p.389-393

2007

Link zum Volltext

Verfügbarkeit prüfen

PPAR[gamma] is reduced in the airways of non-CF bronchiectasis subjects and is inversely correlated with the presence of Pseudomonas aeruginosa.(Research Article)(peroxisome proliferator-activated receptor gamma)

PloS one, 2018-08, Vol.13 (8), p.e0202296

2018

Link zum Volltext

Verfügbarkeit prüfen

Cytokines and Inflammatory Mediators Do Not Indicate Acute Infection in Cystic Fibrosis

Clinical and Diagnostic Laboratory Immunology, 1999-03, Vol.6 (2), p.260

1999

Link zum Volltext

Verfügbarkeit prüfen

Influenza epidemiology, vaccine coverage and vaccine effectiveness in sentinel Australian hospitals in 2013: the Influenza Complications Alert Network

Communicable diseases intelligence quarterly report, 2014-06, Vol.38 (2), p.E143

2014

Link zum Volltext

Verfügbarkeit prüfen

Macrolide Treatment Inhibits Pseudomonas aeruginosa Quorum Sensing in Non-CF Bronchiectasis: An Analysis from the BLESS Trial

Annals of the American Thoracic Society, 2016-07, Article AnnalsATS.201601-044OC

2016

Link zum Volltext

Verfügbarkeit prüfen

Adult Non-Cystic Fibrosis Bronchiectasis Is Characterised by Airway Luminal Th17 Pathway Activation: e0119325

PloS one, 2015-03, Vol.10 (3)

2015

Link zum Volltext

Verfügbarkeit prüfen

Measuring the systemic effects of inhaled beclomethasone: timed morning urine collections compared with 24 hour specimens

Thorax, 1995-12, Vol.50 (12), p.1280-1284

1995

Link zum Volltext

Verfügbarkeit prüfen

Heparin inhibits the immediate response to antigen in the skin and lungs of allergic subjects

The American review of respiratory disease, 1993-01, Vol.147 (1), p.160

1993

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(53)
Berichte
(1)

Sprache

Englisch
(54)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

PPARγ is reduced in the airways of non-CF bronchiectasis subjects and is inversely correlated with the presence of Pseudomonas aeruginosa

Adult non-cystic fibrosis bronchiectasis is characterised by airway luminal Th17 pathway activation

Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial

Airway Mucus Hyperconcentration in Non-Cystic Fibrosis Bronchiectasis

Central Sleep Apnea in Cancer Patients on Opioids

Effect of Albuterol on Maximal Exercise Capacity in Cystic Fibrosis

Macrolide Treatment Inhibits Pseudomonas aeruginosa Quorum Sensing in Non-Cystic Fibrosis Bronchiectasis. An Analysis from the Bronchiectasis and Low-Dose Erythromycin Study Trial

Australasian respiratory and emergency physicians do not use the pneumonia severity index in community-acquired pneumonia

Severe asthma assessment, management and the organisation of care in Australia and New Zealand: expert forum roundtable meetings

Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: A test-negative case control study

Everolimus treatment of abdominal lymphangioleiomyoma in five women with sporadic lymphangioleiomyomatosis

Effect of long-term treatment with azithromycin on disease parameters in cystic fibrosis

Successful Treatment of Severe Cytomegalovirus Infection with Ganciclovir in an Immunocompetent Host

Buteyko breathing techniques in asthma: a blinded randomised controlled trial

Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis

Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study

Clinical and epidemiological profile of patients with severe H1N1/09 pandemic influenza in Australia and New Zealand: an observational cohort study

Effect of a simple educational intervention on the hospital management of community-acquired pneumonia

PPAR[gamma] is reduced in the airways of non-CF bronchiectasis subjects and is inversely correlated with the presence of Pseudomonas aeruginosa.(Research Article)(peroxisome proliferator-activated receptor gamma)

Cytokines and Inflammatory Mediators Do Not Indicate Acute Infection in Cystic Fibrosis

Influenza epidemiology, vaccine coverage and vaccine effectiveness in sentinel Australian hospitals in 2013: the Influenza Complications Alert Network

Macrolide Treatment Inhibits Pseudomonas aeruginosa Quorum Sensing in Non-CF Bronchiectasis: An Analysis from the BLESS Trial

Adult Non-Cystic Fibrosis Bronchiectasis Is Characterised by Airway Luminal Th17 Pathway Activation: e0119325

Measuring the systemic effects of inhaled beclomethasone: timed morning urine collections compared with 24 hour specimens

Heparin inhibits the immediate response to antigen in the skin and lungs of allergic subjects

Suchergebnisse filtern